- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Endometrial Carcinoma (EC) in Austria
Total 1357 results
-
European Organisation for Research and Treatment...University of GlasgowCompletedKidney CancerBelgium, Netherlands, Austria, Hungary, Italy, Turkey, Israel, United Kingdom
-
Lexicon PharmaceuticalsCompletedCarcinoid SyndromeUnited States, Australia, Belgium, Canada, France, Germany, Israel, Spain, Sweden, United Kingdom, Netherlands
-
Merck Sharp & Dohme LLCActive, not recruitingUrothelial CarcinomaAustralia, United States, Chile, Denmark, Israel, Korea, Republic of, Spain
-
Bolt Biotherapeutics, Inc.RecruitingClear Cell Renal Cell Carcinoma | Head and Neck Cancer | Colorectal Cancer | Ovarian Cancer | Triple Negative Breast Cancer | Non-small Cell Lung CancerUnited States
-
Merck Sharp & Dohme LLCRecruitingCarcinoma, Hepatocellular | Colorectal Neoplasms | Esophageal Neoplasms | Endometrial Neoplasms | Pancreatic Ductal Adenocarcinoma | Biliary Tract NeoplasmsIsrael, United States, Australia, Belgium, Chile, France, Korea, Republic of, Netherlands, Spain, New Zealand
-
Boehringer IngelheimCompletedCarcinoma, HepatocellularAustria, France, Germany, Hungary, Netherlands, Poland, Romania, United Kingdom
-
TheRas, Inc., d/b/a BridgeBio Oncology TherapeuticsRecruitingNSCLC | Metastatic Lung Cancer | Non-small Cell Lung Cancer | Advanced Lung Carcinoma | Metastatic Non-Small Cell Lung Cancer | KRAS G12CUnited States, Australia
-
SanofiGroupe Oncologie Radiotherapie Tete et CouCompletedHead and Neck Squamous Cell CarcinomaUnited States, France, Canada, Poland, Germany, Spain, Switzerland, Singapore, Taiwan, Argentina, Hungary, Italy, Chile, Hong Kong, South Africa, Australia, New Zealand
-
BeiGeneRecruitingHead and Neck Cancer | Head and Neck Squamous Cell CarcinomaChina, Italy, Taiwan, Australia, Spain, Korea, Republic of, France, United Kingdom, Thailand, Canada, United States, Georgia, Singapore, Turkey
-
AstraZenecaRecruitingCervical Cancer | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Non-small Cell Lung Cancer | Biliary Cancer | Additional Indications Below for Module 4 and 5 | Small Cell Lung Cancer Only in Module 5Canada, Spain, China, Korea, Republic of, Italy, Poland, United States, Australia, United Kingdom, Japan, Hungary, Russian Federation, Czechia
-
Novartis PharmaceuticalsCompletedNon Small Cell Lung CancerBelgium, Australia, Germany
-
PfizerCompletedNon Small Cell Lung CancerUnited States, Australia
-
AbbVieAvailableNon-Small Cell Lung Cancer (NSCLC)Australia, Hong Kong, Israel, United States, Germany
-
PfizerTerminatedCarcinoma, Islet Cell | Carcinoma, PancreasUnited States, Canada, Belgium, Spain, Australia, Germany, Korea, Republic of, Taiwan, United Kingdom, France, Italy
-
University of SydneyAstraZeneca; Australasian Lung Cancer Trials GroupActive, not recruitingEGFR Mutant Advanced Non Small Cell Lung CancerTaiwan, Australia
-
University of Texas Southwestern Medical CenterCompletedNon-small Cell Lung CancerUnited States
-
Incyte CorporationTerminatedMetastatic Urothelial Carcinoma | Unresectable Urothelial CarcinomaSpain, France, United States, Italy, Japan, Ireland, Slovakia, Austria, Belgium, Canada, Finland, Germany, Poland, Portugal, Romania, United Kingdom
-
Sonnet BioTherapeuticsHoffmann-La RocheRecruitingAdvanced Solid Tumor | Platinum-resistant Ovarian CancerUnited States, Australia
-
IO BiotechMerck Sharp & Dohme LLC; Theradex; AlmacRecruitingMelanoma | Squamous Cell Carcinoma of Head and NeckUnited States, Australia, Denmark, Spain, France, Germany
-
MacroGenicsTerminatedMelanoma | Soft Tissue Sarcoma | Clear Cell Renal Cell Carcinoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Mesothelioma | Squamous Cell Carcinoma of the Head and Neck | Bladder Cancer | Colon Cancer | Thyroid CancerUnited States, Australia, Canada
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Ovarian Undifferentiated Carcinoma | Ovarian Clear Cell Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Mucinous... and other conditionsUnited States, Korea, Republic of, Japan
-
Hoffmann-La RocheCompletedBasal Cell CarcinomaUnited States, Spain, France, Germany, Netherlands, Russian Federation, Italy, Mexico, Austria, Canada
-
Peter MacCallum Cancer Centre, AustraliaTerminated
-
Novartis PharmaceuticalsTerminatedMetastatic Pancreatic Ductal AdenocarcinomaBelgium, Finland, Taiwan, Australia, Germany, Spain, Italy, Austria, Czechia, Switzerland, Singapore, United Kingdom, United States, France
-
Genentech, Inc.CompletedHead and Neck CancerUnited States, Germany, Spain, France, Australia, Hungary, Belgium, Bulgaria, United Kingdom, Italy, Romania
-
BayerCompletedCarcinoma, HepatocellularJapan, Turkey, Austria, Czechia, Hungary, Israel, Russian Federation, Slovakia, Switzerland, India, Korea, Republic of, France, Mexico, Indonesia, Singapore, Thailand, Canada, Greece, Netherlands, Spain, Taiwan, Poland, Brazil, China, D... and more
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma | Advanced Renal Cell CarcinomaSpain, Germany, United States, Austria, Czechia, United Kingdom, Argentina, Hungary, France, Canada, Chile
-
Panbela Therapeutics, Inc.CompletedPancreatic Cancer | Ductal Adenocarcinoma of the PancreasUnited States, Australia
-
Breast Cancer Trials, Australia and New ZealandETOP IBCSG Partners Foundation; Breast International GroupRecruitingEarly Stage Breast CarcinomaTaiwan, Australia, Spain, New Zealand, Ireland, Italy, Argentina, Switzerland, Chile
-
Eisai Inc.Active, not recruitingCarcinoma, HepatocellularUnited States, Spain, United Kingdom, Australia, Sweden, Italy, Austria, Germany, Portugal, Russian Federation
-
Eisai Inc.PharmaBio Development Inc.Terminated
-
Incyte CorporationCompletedMetastatic Melanoma | Unresectable Melanoma | Metastatic Urothelial Cancer | Metastatic Non-small Cell Lung Cancer | Locally Advanced Renal Cell Carcinoma | Locally Advanced Urothelial Cancer | Metastatic Clear-Cell Renal Cell CarcinomaFrance, Spain, United States, Italy, Austria, Romania, Poland, Hungary
-
Janssen Research & Development, LLCCompleted
-
BayerCompletedLiver NeoplasmsUnited States, Canada, Japan, Spain, Sweden, Belgium, Argentina, Austria, Greece, Italy, Korea, Republic of, Netherlands, Russian Federation, Taiwan, Turkey, China, Denmark, Egypt, France, Saudi Arabia, Thailand
-
Formation BiologicsTerminatedNon Small Cell Lung Cancer | Triple Negative Breast Cancer | Head and Neck Squamous Cell Carcinoma | Solid Tumor, AdultUnited States
-
Zumutor Biologics Inc.RecruitingColorectal Cancer | Esophageal Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreas Adenocarcinoma | Diffuse Large B Cell Lymphoma | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Biliary Tract Cancer | High Grade Ovarian Serous AdenocarcinomaUnited States
-
Hoosier Cancer Research NetworkBionomics LimitedCompletedRenal Cell CarcinomaUnited States, Australia, Singapore
-
Arbeitsgemeinschaft medikamentoese TumortherapieEli Lilly and Company; Novartis; Pfizer; Hoffmann-La Roche; AstraZeneca; Seagen Inc.; Caris Life Science and other collaboratorsRecruiting
-
PfizerCompletedCarcinoma, Renal CellAustralia, Korea, Republic of, Brazil, Taiwan, Mexico, Argentina
-
Dynavax Technologies CorporationMerck Sharp & Dohme LLCTerminatedMetastatic Melanoma | Head Neck CancerUnited States, Germany, New Zealand, Australia
-
ExelixisRecruitingRenal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Solid Tumor | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma | Metastatic Castration-resistant Prostate CancerUnited States, Poland, Spain, Switzerland, Austria, Australia, Belgium, Israel, Italy, New Zealand, France, Germany, United Kingdom
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHepatocellular CarcinomaUnited States, Australia, Austria, Belgium, Canada, China, Czechia, France, Germany, Hong Kong, Israel, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
AmgenCompletedCancer | Breast Cancer | Anemia | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Bladder Cancer | Endometrial Cancer | Solid Tumors | Renal CancerFrance, Italy, Netherlands, Belgium, Romania, Poland, Austria, Greece, Germany
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung CancerTaiwan, Korea, Republic of, Brazil, China, Australia, Mexico
-
Bristol-Myers SquibbExelixisCompletedSmall Cell Lung CarcinomaUnited States, Canada, Australia, France, Ireland
-
Arcus Biosciences, Inc.RecruitingCervical Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Bladder Cancer | Advanced Cancer | Non-Small Cell Lung Cancer (NSCLC) | Advanced Malignancies | Renal Cell Carcinoma (RCC) | Triple Negative Breast Cancer (TNBC) | Head and Neck Squamous Cell Carcinoma (HNSCC) | Gastroesophageal-junction...United States, Australia
-
National Cancer Centre, SingaporeNational Medical Research Council (NMRC), Singapore; Innogene Kalbiotech Pte...Active, not recruitingCarcinoma, Squamous Cell of Head and NeckPhilippines, Thailand, Korea, Republic of, Australia, Taiwan, India, Saudi Arabia, Singapore, South Africa, Egypt, Cuba, Indonesia, Malaysia
-
AccentureCompletedRecurrent Platinum-resistant Ovarian CancerAustralia, Russian Federation, United Kingdom
-
Immatics Biotechnologies GmbHCompletedRenal Cell CarcinomaSpain, Germany, Bulgaria, United Kingdom, Austria, Hungary, Poland, Romania, Slovakia, Switzerland
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdCompletedHead and Neck CancerItaly, United States, Israel, Japan, Australia, Austria, Brazil, France, Germany, Greece, Ireland, Korea, Republic of, Mexico, Poland, Spain, Switzerland, Taiwan, United Kingdom